Works by Arafa, El-Shaimaa A.


Results: 31
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer's Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 Signalling.

    Published in:
    Medicina (1010660X), 2024, v. 60, n. 11, p. 1805, doi. 10.3390/medicina60111805
    By:
    • Elariny, Hemat A.;
    • Kabel, Ahmed M.;
    • Selim, Heba Mohammed Refat M.;
    • Helal, Azza I.;
    • Abdelrahman, Doaa;
    • Borg, Hany M.;
    • Elkady, Mennatallah A.;
    • Dawood, Lamees M.;
    • El-Badawy, Mohamed F.;
    • Almalawi, Haifa Faisal A.;
    • Arafa, El-Shaimaa A.;
    • Alsufyani, Shuruq E.;
    • Arab, Hany H.
    Publication type:
    Article
    19

    Targeting the Sirtuin–1/PPAR–Gamma Axis, RAGE/HMGB1/NF-κB Signaling, and the Mitochondrial Functions by Canagliflozin Augments the Protective Effects of Levodopa/Carbidopa in Rotenone-Induced Parkinson's Disease.

    Published in:
    Medicina (1010660X), 2024, v. 60, n. 10, p. 1682, doi. 10.3390/medicina60101682
    By:
    • Elkady, Mennatallah A.;
    • Kabel, Ahmed M.;
    • Dawood, Lamees M.;
    • Helal, Azza I.;
    • Borg, Hany M.;
    • Atia, Hanan Abdelmawgoud;
    • Sabry, Nesreen M.;
    • Moustafa, Nouran M.;
    • Arafa, El-Shaimaa A.;
    • Alsufyani, Shuruq E.;
    • Arab, Hany H.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31